Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

Frontiers in Neurology

Rajeev Kumar³  Nirmal Surya⁵  Koravangattu Valsraj Menon⁷  Paolo Prandi⁸  Abderrahmane Chahidi^1,11  Susana Mederer Hengstl^1,13  Harvey Yang^1,14  Sandra Martinez^1,15  Mihriban Heval Ozgen^1,16  Mandana Toosi^1,19  Nithya Hariya Mohan^2,20  Sonu Bhaskar^2,27  Simon Israeli-Korn^2,28  Pravin Thomas^2,28  Sailaja Golla^2,28  Vijay Kumar Chattu^2,28  Jasvinder Chawla^2,28  Daniel Ray^2,28  John Codrington^2,28  Eva María Jiménez González^2,28  Sian Bradley^2,28  Bindu Menon^2,28 

[1] Anton de Kom Universiteit van Suriname Faculteit der Medische Wetenschappen, Paramaribo, Suriname;Australian National University, Canberra, ACT, Australia;Hines VA Hospital, Chicago, IL, United States;Medical Research Centre, and Epilepsy Foundation India, Mumbai, India;NHS Foundation Trust, Birmingham, United Kingdom;NSW Brain Clot Bank, Ingham Institute for Applied Medical Research and South West Sydney Clinical School, The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia;0Department of Forensic Psychology, Forensic Psychology and Forensic Sciences Institute, Ministry of Justice, Granada, Spain;;0Department of Psychiatry, Hamad Medical Center, Qatar &1Department of Neurology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy;1LodeStone Center for Behavioral Health and Eastern Illinois University, Chicago, IL, United States;2Chengalpattu Medical College and Hospital, Chengalpattu, India;;2Farr Institute of Health Informatics, University College London (UCL) &3Department of Psychiatry, South London and Maudsley NHS Foundation Trust, Kings Health Partners, London, United Kingdom;3Texas Institute for Neurological Disorders, Dallas, TX, United States;;4Department of Neurology, Bombay Hospital &;5Department of Neurology, Academic Hospital Paramaribo &6Department of Neurology, Hospital da Restauração, Recife, Brazil;7Department of Psychiatry, Parnassia Psychiatric Institute, The Hague, Netherlands;8Curium-Leiden University Medical Centre, Oegstgeest, Netherlands;9Department of Laboratory Medicine, Academic Hospital Paramaribo and Anton de Kom Universiteit van Suriname Faculteit der Medische Wetenschappen, Paramaribo, Suriname;Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada;Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia;Department of Neurology, Apollo Hospitals, Nellore, India;;Department of Neurology, Loyola University Medical Center &Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan and Sackler School of Medicine, Movement Disorders Institute, Tel Aviv University, Tel Aviv-Yafo, Israel;Department of Neurology, University Hospitals NHS Foundation Trust, Birmingham, United Kingdom;;Neurovascular Imaging Laboratory &Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†;The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia;

关键词: coronavirus disease 2019 (COVID-19);    chronic neurological disease;    healthcare services;    guidelines;    neurodegenerative disorders;    protocols;   

DOI  :  10.3389/fneur.2020.00664

来源: DOAJ

【 摘 要 】

With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a pressing need for governing bodies including national and international professional associations, health ministries and health institutions to harmonize policies, guidelines, and recommendations relating to the management of chronic neurological conditions. These harmonized guidelines should ensure patient continuity across the spectrum of hospital and community care including the well-being, safety, and mental health of the patients, their care partners and the health professionals involved. This article provides an in-depth analysis of the impact of COVID-19 on chronic neurological conditions and specific recommendations to minimize the potential harm to those at high risk.

【 授权许可】

Unknown